MEDFIN Share Price Performance
SEK 0
-3.65 (-100.00%)
Price SEK 0
Share Pricen/a
Medicortex International AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
MEDFIN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Medicortex International AB (publ) Key Details
About MEDFIN
- Founded
- 2014
- Employees
- 3
- CEO
- WebsiteView website
Medicortex International AB (publ), through its subsidiary, Medicortex Finland Oyj, develops diagnostic tests based on biomarkers for traumatic brain injury, concussions, and other neurodegenerative conditions. It is developing ProbTBI, a diagnostic test for urine; and IndicateTBI, a diagnostic test for saliva. The company was formerly known as Nosium AB (publ) and changed its name to Medicortex International AB (publ) in July 2026. Medicortex International AB (publ) was founded in 2014 and is based in Stockholm, Sweden.
